Studies show that GLP-1 medications can impact gastric motility, which can contribute to symptoms like bloating and side effects like sulfur burps, especially in people who are sensitive to changes in their digestion
A1C -1.5% at 12 mg (-1.6% at 9 mg) TRIUMPH-3 obesity with established cardiovascular disease (July 23, 2026) 22.6% weight loss at 12 mg over 80 weeks ADA 86th Scientific Sessions (Jun 6-10, 2026, New Orleans) the full TRIUMPH-1 + TRANSCEND-T2D-1 panel, the most detailed public presentation of the Phase 3 data see our ADA 2026 retatrutide coverage Still expected: TRIUMPH-5 (head-to-head vs tirzepatide, NCT06662383): Phase 3 obesity efficacy comparison
Nutrex L-Carnitine 3000 supports energy, fat metabolism, and daily performance with a fast-absorbing liquid formula
Science 130:432437 Eagle H, Piez KA, Oyama VI (1961) The biosynthesis of cystine in human cell cultures
A thorough history and exam, and possibly x-rays, may diagnose a different condition with a different treatment plan